v3.26.1
Share-Based Compensation - Summary of Outstanding Activity of Options, Restricted Stock and Restricted Stock Units under MRI EICP (Detail) - MRI EICP [Member] - $ / shares
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Restricted Shares [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Shares, Beginning of period 0 626,108
Number of Shares, Granted 0 0
Number of Shares, Vested 0 0
Number of Shares, Forfeited 0  
Number of Shares, End of period 0 626,108
Weighted Average Grant Date Fair Value, Beginning of period $ 0 $ 11.93
Weighted Average Grant Date Fair Value, Granted 0 0
Weighted Average Grant Date Fair Value, Vested 0 0
Weighted Average Grant Date Fair Value, Forfeited 0  
Weighted Average Grant Date Fair Value, End of period $ 0 $ 11.93
Restricted Stock Units [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Shares, Beginning of period 130,000 170,000
Number of Shares, Granted 0 0
Number of Shares, Vested 0 0
Number of Shares, Forfeited 0  
Number of Shares, End of period 130,000 170,000
Weighted Average Grant Date Fair Value, Beginning of period $ 4.97 $ 7.63
Weighted Average Grant Date Fair Value, Granted 0 0
Weighted Average Grant Date Fair Value, Vested 0 0
Weighted Average Grant Date Fair Value, Forfeited 0  
Weighted Average Grant Date Fair Value, End of period $ 4.97 $ 7.63
Options [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Shares, Beginning of period 2,100,000 2,325,000
Number of Shares, Granted 0 0
Number of Shares, Vested 0 0
Number of Shares, Forfeited 0  
Number of Shares, End of period 2,100,000 2,325,000
Weighted Average Grant Date Fair Value, Beginning of period $ 6.77 $ 7.04
Weighted Average Grant Date Fair Value, Granted 0 0
Weighted Average Grant Date Fair Value, Vested 0 0
Weighted Average Grant Date Fair Value, End of period $ 6.77 $ 7.04